Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan

Aug.21.2025
Smoore's 2025 first-half performance: Revenue rose 18.3% to 6.013 billion yuan, with self - brand revenue up 14.1% to 1.274 billion yuan
In the first half of 2025, Smoore's revenue reached 6.013 billion yuan, up by 18.3%. The adjusted net profit was 737 million yuan, down by 2.1%. The ToB business revenue was 4.739 billion yuan, up by 19.5%, while the self - brand business revenue was 1.274 billion yuan, up by 14.1%.

Key points:

 

·Overall performance:

Total revenue was 6.013 billion yuan, an increase of 18.3% year-on-year. Net profit for the period was 492 million yuan, a decrease of 28% year-on-year. Adjusted net profit was 737 million yuan, a slight decrease of 2.1% year-on-year.

 

·Performance of business segments:

Total revenue from ToB business reached 4.739 billion RMB, a year-on-year increase of 19.5%. Revenue from proprietary brand businesses amounted to 1.274 billion RMB, representing a 14.1% increase compared to the previous year.

 

·Regional market performance:

Europe and other countries: Revenue of RMB 2.734 billion, a year-on-year increase of 38%. U.S. market: Revenue of RMB 1.888 billion, a year-on-year increase of 1.5%. Mainland China: Revenue of RMB 0.117 billion, a year-on-year decrease of 6.1%.

 

·New business highlights:

HNB products: Support strategic clients to launch high-end series in the Japanese market and plan nationwide promotion in September. Special purpose atomization and medical, beauty business: Revenue of Lanmei beauty device reached 31 million RMB, a year-on-year increase of 2595%.

 

·Research and Development investment:

Research and development expenditures: 723 million RMB, a decrease of 4.9% year-on-year. Future direction: Focus on HNB and atomized medical sector.

 


 

According to a message from Smoore's official website on August 20th, Smoore International (06969.HK) announced its performance for the first half of 2025: the group achieved revenue of approximately RMB 6.013 billion, an 18.3% increase year-on-year; net profit for the period was approximately RMB 492 million, a 28% decrease year-on-year; excluding non-cash expenses such as share-based payments, adjusted net profit was approximately RMB 737 million, a slight decrease of 2.1% year-on-year.

 

Among them, the revenue of ToB business reached 4.739 billion yuan, a year-on-year increase of 19.5%, mainly driven by the increasing demand for compliant products following the European market's ban on disposable electronic cigarettes. The revenue of the self-owned brand business reached approximately 1.274 billion yuan, representing a year-on-year increase of 14.1%.

 

By region, revenue (ToB) in Europe and other countries increased by 38% year-on-year to 27.34 billion yuan, revenue (ToB) in the US market was approximately 18.88 billion yuan, a year-on-year growth of 1.5%, and revenue (ToB) in mainland China decreased by about 6.1% year-on-year to 1.17 billion yuan.

 

Smoore stated that in the HNB (Heat-Not-Burn) product field, the group has supported strategic clients in launching high-end series in the Japanese market and plans to promote nationwide in September; the special purpose atomization and medical, beauty business continue to advance, with the revenue of the Lan Zhi beauty instrument reaching 310 million yuan, a year-on-year increase of 2595%.

 

In addition, Smoore's research and development expenses were 723 million yuan, a decrease of 4.9% from the previous year, with a focus on HNB and atomization medical directions in the future.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
JTI Philippines has expanded the Nordic Spirit nicotine pouch portfolio in the Philippines with two new variants, Dark Pop and Red Frost. Both products maintain the brand’s tobacco-free nicotine pouch positioning, with Dark Pop featuring a fizzy cola profile with citrus and sweet notes, while Red Frost combines cool mint with sweet red berry flavors. The two variants are now available through Philippine online retail channels.
Aug.18
Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
Scottish Vape Display Rules Could Cost Businesses £61 Million, Affecting More Than 11,000 Retail Outlets
A Scottish government impact assessment estimates that proposed vape display and packaging rules could create up to £61 million ($82 million) in compliance costs for businesses, affecting more than 11,000 retail outlets. The estimated costs are mainly linked to inventory adjustments, retail storage changes and the resources required for businesses to understand and implement the new requirements. The measures form part of the UK’s broader efforts to tighten vape regulation, particularly around product displays, packaging and sales practices.
Aug.10